PRCSG News

Abstracts  / Posters / Presentations

 

 21 PANLAR 2019, April 27 - 30

  • Efficacy and safety of intravenous golimumab in patients with juvenile idiopathic arthritis: Results from a Phase 3 open-label study (#323)

 

*******************************************************************************************

April 2019 - FDA approves Benlysta (belimumab) for children with lupus who are five years old or above

 

September 2018 - FDA approves subcutaneous formulation of ACTEMRA for systemic JIA 

 

Revised Common Rule: educational videos created by OHRP

 

May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis